Seek Returns logo

NMR vs. SNEX: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at NMR and SNEX, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

NMR trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, SNEX is a standard domestic listing.

SymbolNMRSNEX
Company NameNomura Holdings, Inc.StoneX Group Inc.
CountryJapanUnited States
GICS SectorFinancialsFinancials
GICS IndustryCapital MarketsCapital Markets
Market Capitalization21.62 billion USD5.16 billion USD
ExchangeNYSENasdaqGS
Listing DateDecember 17, 2001March 6, 1995
Security TypeADRCommon Stock

Historical Performance

This chart compares the performance of NMR and SNEX by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

NMR vs. SNEX: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolNMRSNEX
5-Day Price Return-2.06%5.16%
13-Week Price Return23.60%14.56%
26-Week Price Return2.20%22.25%
52-Week Price Return23.08%87.02%
Month-to-Date Return6.22%1.65%
Year-to-Date Return14.62%51.34%
10-Day Avg. Volume10.62M0.55M
3-Month Avg. Volume12.16M0.45M
3-Month Volatility20.02%41.76%
Beta1.490.54

Profitability

Return on Equity (TTM)

NMR

9.87%

Capital Markets Industry

Max
38.97%
Q3
21.61%
Median
13.77%
Q1
8.31%
Min
-4.25%

NMR’s Return on Equity of 9.87% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

SNEX

16.16%

Capital Markets Industry

Max
38.97%
Q3
21.61%
Median
13.77%
Q1
8.31%
Min
-4.25%

SNEX’s Return on Equity of 16.16% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

NMR vs. SNEX: A comparison of their Return on Equity (TTM) against the Capital Markets industry benchmark.

Net Profit Margin (TTM)

NMR

7.19%

Capital Markets Industry

Max
66.67%
Q3
35.11%
Median
23.49%
Q1
13.63%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, NMR’s Net Profit Margin of 7.19% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

SNEX

0.23%

Capital Markets Industry

Max
66.67%
Q3
35.11%
Median
23.49%
Q1
13.63%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, SNEX’s Net Profit Margin of 0.23% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

NMR vs. SNEX: A comparison of their Net Profit Margin (TTM) against the Capital Markets industry benchmark.

Operating Profit Margin (TTM)

NMR

9.96%

Capital Markets Industry

Max
86.40%
Q3
46.46%
Median
32.80%
Q1
18.32%
Min
-21.87%

NMR’s Operating Profit Margin of 9.96% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

SNEX

0.30%

Capital Markets Industry

Max
86.40%
Q3
46.46%
Median
32.80%
Q1
18.32%
Min
-21.87%

SNEX’s Operating Profit Margin of 0.30% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

NMR vs. SNEX: A comparison of their Operating Profit Margin (TTM) against the Capital Markets industry benchmark.

Profitability at a Glance

SymbolNMRSNEX
Return on Equity (TTM)9.87%16.16%
Return on Assets (TTM)0.58%0.97%
Net Profit Margin (TTM)7.19%0.23%
Operating Profit Margin (TTM)9.96%0.30%
Gross Profit Margin (TTM)39.95%1.89%

Financial Strength

Current Ratio (MRQ)

NMR

0.23

Capital Markets Industry

Max
3.76
Q3
1.89
Median
1.01
Q1
0.54
Min
-0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

SNEX

0.47

Capital Markets Industry

Max
3.76
Q3
1.89
Median
1.01
Q1
0.54
Min
-0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

NMR vs. SNEX: A comparison of their Current Ratio (MRQ) against the Capital Markets industry benchmark.

Debt-to-Equity Ratio (MRQ)

NMR

10.44

Capital Markets Industry

Max
6.62
Q3
2.84
Median
1.02
Q1
0.32
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

SNEX

8.24

Capital Markets Industry

Max
6.62
Q3
2.84
Median
1.02
Q1
0.32
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

NMR vs. SNEX: A comparison of their Debt-to-Equity Ratio (MRQ) against the Capital Markets industry benchmark.

Interest Coverage Ratio (TTM)

NMR

--

Capital Markets Industry

Max
126.03
Q3
60.98
Median
11.77
Q1
4.95
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

SNEX

237.00

Capital Markets Industry

Max
126.03
Q3
60.98
Median
11.77
Q1
4.95
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

NMR vs. SNEX: A comparison of their Interest Coverage Ratio (TTM) against the Capital Markets industry benchmark.

Financial Strength at a Glance

SymbolNMRSNEX
Current Ratio (MRQ)0.230.47
Quick Ratio (MRQ)0.230.47
Debt-to-Equity Ratio (MRQ)10.448.24
Interest Coverage Ratio (TTM)--237.00

Growth

Revenue Growth

NMR vs. SNEX: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

NMR vs. SNEX: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

NMR

3.55%

Capital Markets Industry

Max
10.26%
Q3
4.86%
Median
2.78%
Q1
1.22%
Min
0.00%

NMR’s Dividend Yield of 3.55% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

SNEX

0.00%

Capital Markets Industry

Max
10.26%
Q3
4.86%
Median
2.78%
Q1
1.22%
Min
0.00%

SNEX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

NMR vs. SNEX: A comparison of their Dividend Yield (TTM) against the Capital Markets industry benchmark.

Dividend Payout Ratio (TTM)

NMR

66.06%

Capital Markets Industry

Max
200.72%
Q3
101.92%
Median
57.97%
Q1
32.36%
Min
0.00%

NMR’s Dividend Payout Ratio of 66.06% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

SNEX

0.00%

Capital Markets Industry

Max
200.72%
Q3
101.92%
Median
57.97%
Q1
32.36%
Min
0.00%

SNEX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

NMR vs. SNEX: A comparison of their Dividend Payout Ratio (TTM) against the Capital Markets industry benchmark.

Dividend at a Glance

SymbolNMRSNEX
Dividend Yield (TTM)3.55%0.00%
Dividend Payout Ratio (TTM)66.06%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

NMR

9.31

Capital Markets Industry

Max
58.89
Q3
31.00
Median
18.54
Q1
12.09
Min
5.24

In the lower quartile for the Capital Markets industry, NMR’s P/E Ratio of 9.31 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

SNEX

16.84

Capital Markets Industry

Max
58.89
Q3
31.00
Median
18.54
Q1
12.09
Min
5.24

SNEX’s P/E Ratio of 16.84 is within the middle range for the Capital Markets industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

NMR vs. SNEX: A comparison of their Price-to-Earnings Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Sales Ratio (TTM)

NMR

0.67

Capital Markets Industry

Max
14.49
Q3
7.41
Median
4.68
Q1
2.25
Min
0.04

In the lower quartile for the Capital Markets industry, NMR’s P/S Ratio of 0.67 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

SNEX

0.04

Capital Markets Industry

Max
14.49
Q3
7.41
Median
4.68
Q1
2.25
Min
0.04

SNEX’s P/S Ratio of 0.04 falls below the typical floor for the Capital Markets industry. This could suggest the stock is overlooked or deeply undervalued relative to its sales, but may also reflect significant market concerns about its future.

NMR vs. SNEX: A comparison of their Price-to-Sales Ratio (TTM) against the Capital Markets industry benchmark.

Price-to-Book Ratio (MRQ)

NMR

0.83

Capital Markets Industry

Max
9.48
Q3
4.94
Median
2.42
Q1
1.21
Min
0.38

NMR’s P/B Ratio of 0.83 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

SNEX

2.25

Capital Markets Industry

Max
9.48
Q3
4.94
Median
2.42
Q1
1.21
Min
0.38

SNEX’s P/B Ratio of 2.25 is within the conventional range for the Capital Markets industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

NMR vs. SNEX: A comparison of their Price-to-Book Ratio (MRQ) against the Capital Markets industry benchmark.

Valuation at a Glance

SymbolNMRSNEX
Price-to-Earnings Ratio (TTM)9.3116.84
Price-to-Sales Ratio (TTM)0.670.04
Price-to-Book Ratio (MRQ)0.832.25
Price-to-Free Cash Flow Ratio (TTM)3.323.03